"Profit Warning" CHANGMAO BIO is expected to have a mid-term loss expanded to approximately RMB 24 million to 27 million

CHANGMAO BIO (00954.HK) issued a profit warning, expecting a consolidated net loss of approximately RMB 24 million to 27 million for the interim period ending June 30, 2025, compared to a net loss of approximately RMB 18.786 million for the same period in 2024. This is mainly due to a decline in product sales prices and intense market competition, leading to a decrease in sales revenue and gross profit, as well as an increase in interest expenses included in the consolidated income statement